Armata Pharmaceuticals (ARMP) Depreciation and Depletion (2013 - 2026)

Armata Pharmaceuticals has disclosed Depreciation and Depletion across 14 years of filings, most recently posting $457000.0 for Q1 2026.

• Depreciation and Depletion for Q1 2026 came in at $457000.0, up 21.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (up 13.27% YoY), and the FY2025 annual result was $1.5 million, up 15.55% from the prior year.
• Depreciation and Depletion came in at $457000.0 for Q1 2026 at Armata Pharmaceuticals, up from $431000.0 in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $457000.0 in Q1 2026 to a low of $200000.0 in Q2 2022.
• The 5-year median for Depreciation and Depletion is $300000.0 (2022), against an average of $300941.2.
• Across the five-year window, Depreciation and Depletion plunged 33.33% in 2022 and jumped 50.0% in 2024, its largest moves.
• Armata Pharmaceuticals' Depreciation and Depletion stood at $300000.0 in 2022, then changed by 0.0% to $300000.0 in 2023, then soared by 41.67% to $425000.0 in 2024, then gained by 1.41% to $431000.0 in 2025, then gained by 6.03% to $457000.0 in 2026.
• The last three Depreciation and Depletion figures came in at $457000.0 (Q1 2026), $431000.0 (Q4 2025), and $400000.0 (Q3 2025), per Business Quant data.